{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-026308","form_type":"8-K","ticker":null,"cik":"0001513818","company_name":"Aravive, Inc.","filed_at":"2023-09-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.158335+00:00","generated_at":"2026-06-10T13:23:37.194404+00:00","sec_items":["3.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Aravive fails to meet three Nasdaq listing standards; cure period to March 13, 2024","bullets":["MVLS below $50M for 30 consecutive business days (Aug 3-Sep 14, 2023); 180-day cure ends March 13, 2024.","MVPHS below $15M over same period; compliance requires closing at $15M+ for 10 consecutive days.","Minimum bid price below $1.00 for 30 consecutive days; same cure period applies.","If not cured by March 13, 2024, Nasdaq may delist; company can appeal or apply to transfer to Nasdaq Capital Market."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-026308","json":"https://secwatch.observer/filing/0001437749-23-026308.json","markdown":"https://secwatch.observer/filing/0001437749-23-026308.md","text":"https://secwatch.observer/filing/0001437749-23-026308.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1513818/000143774923026308/0001437749-23-026308-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1513818/000143774923026308/arav20230918_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T13:23:37.194404+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"85e0d13a1d4e27669ca4163168b41f4ecf8cd6eb","claim":"Aravive, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(A), 5450(b)(2)(C)).","evidence_excerpt":"ifying the Company that for the preceding 30 consecutive business days (August 3, 2023 through September 14, 2023), the market value of the Company’s listed securities (“MVLS”) did not maintain a minimum market value of $50,000,000 (the “Minimum MVLS Requirement”) as required by Nasdaq Listing Rule 5450(b)(2)(A). The notification received has no immediate effect on the Company's continued listing on the Nasdaq Global Market, subject to the Company's compliance with the other continued listing requirements. In accordance with Nasdaq Listing Rule 5810(c)(3)(C), the Company has a compliance perio","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1513818/000143774923026308/0001437749-23-026308-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"market value"},{"label":"Rules","value":"5450(b)(2)(A), 5450(b)(2)(C)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}